Results 211 to 220 of about 3,216,105 (293)

Validation and clinical correlates of the Turkish version of the methotrexate intolerance and severity assessment (MISA) questionnaire in rheumatoid arthritis. [PDF]

Intern Emerg Med
Cinakli H, Alp G, Aysin İK, Akar S, Solmaz D.   +4 more
europepmc   +1 more source

Physical and mental disability is evident 8 years after diagnosis in early rheumatoid arthritis despite contemporary medication and non-pharmacological interventions. [PDF]

Clin Rheumatol
Thyberg I, Husberg M, Kastbom A.
europepmc   +1 more source

Abatacept, Golimumab, and Sarilumab as Selected Bio-Originator Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action in Their Current Use in Treatment. [PDF]

J Clin Med
Kawczak P, Feszak IJ, Bączek T.
europepmc   +1 more source

Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study). [PDF]

J Clin Med
Mata-Marín JA, Apaez-Iglesias M, Cano-Díaz AL, Sánchez-Navarro JP, Fernández-Madinaveitia DE, Barriga-Angulo G, Triana-González S, Chaparro-Sánchez A, Pompa-Mera EN, Gaytán-Martínez JE.   +9 more
europepmc   +1 more source

Detection of substantial numbers of latent tuberculosis and positive hepatitis B serology results in rheumatology patients preparing to receive intensified immunosuppressive therapy in a low-prevalence country: why screening still matters. [PDF]

Clin Rheumatol
Feuchtenberger M, Kovacs MS, Nigg A, Schäfer A.   +3 more
europepmc   +1 more source

Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry. [PDF]

Rheumatol Ther
Sonomoto K, Nakayamada S, Tanaka H, Nagayasu A, Tanaka Y.   +4 more
europepmc   +1 more source

The role of IL-37 and IL-38 in rheumatoid arthritis, the potential clinical applications in precision medicine. [PDF]

Front Immunol
Zhang H, Ye Y, Ling X, Hambly BD, Bao S.
europepmc   +1 more source

Progress in targeted therapy for ankylosing spondylitis: A review. [PDF]

Medicine (Baltimore)
Wang J, Lou W, Li Y, Jiang Y, Jiang X, Yang L.   +5 more
europepmc   +1 more source

[Local antirheumatic agents].

Terapevticheskii arkhiv, 1990
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Safe Use of Antirheumatic Agents in Patients with Comorbidities

Rheumatic Disease Clinics of North America, 2012
The burden of comorbid diseases is high among patients with rheumatoid arthritis (RA). These are often systemic manifestations of RA but may be chronic conditions that predate or develop post-RA diagnosis. Increased mortality in RA is predominantly from nonarticular causes.
Ashima Makol, Kerry Wright, Eric L. Matteson   +2 more
openaire   +4 more sources